Life sciences news
-
Bio INX closes its first funding round
Monday September 19th 2022
Read more
-
Possible therapeutic targets identified for ALS and frontotemporal dementia
Wednesday September 14th 2022
Read more
-
ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers
Monday September 12th 2022
Read more
-
Precirix enters into collaboration with Eckert & Ziegler for the development of its 68Ga-based compounds
Monday September 12th 2022
Read more
-
Carroucell raises €1.5 million to introduce breakthrough microcarriers and customizable processes to cell and gene therapy market
Thursday September 8th 2022
Read more
-
New three-year BIMZELX®▼ (bimekizumab) data reinforce long-term maintenance of complete skin clearance in moderate to severe plaque psoriasis
Wednesday September 7th 2022
Read more
-
BioLizard is now an Official Illumina Connected Analytics Implementation Partner
Monday September 5th 2022
Read more
-
flanders.bio has relocated!
Monday September 5th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Nieuwe investering voor HERAN Partners: Aspect Analytics
Monday September 5th 2022
Read more
-
Pathomation announces new release of the “My Pathomation” cloud platform for digital pathology
Friday September 2nd 2022
Read more
-
Biocartis initiates commercialization in Europe of SkylineDx’s innovative Merlin™ Assay (CE-IVD) for melanoma patients
Thursday September 1st 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
